HighMark Wealth Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
HighMark Wealth Management's NEO Position: Q2 2026 in Review
HighMark Wealth Management increased its NeoGenomics (NEO) stake by 5.6% in Q2 2026, buying an estimated $316K and bringing the position to 612,534 shares worth $8.94M. The position accounts for 2.99% of the portfolio, ranked #8.
HighMark Wealth Management first reported a position in NEO in Q2 2020 and has held it in 25 quarters since. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- HighMark Wealth Management held 612,534 shares of NeoGenomics worth $8.94M as of Q2 2026.
- HighMark Wealth Management bought 32,700 NeoGenomics shares in Q2 2026, an estimated $316K.
- NeoGenomics made up 2.99% of HighMark Wealth Management's portfolio in Q2 2026, its #8 holding.
- HighMark Wealth Management first reported a position in NeoGenomics in Q2 2020 and has held it in 25 quarters since.
- 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.